New treatments for ADHD
- January 21, 2022
- The REACH Institute
- ADHD Medication,
Newer treatments approved by the Food and Drug Administration (FDA) for pediatric patients with attention-deficit/hyperactivity disorder (ADHD) include two medications that address some of the common issues families have with standard stimulant treatments. Another development is use of devices to manage ADHD symptoms.
Categories
- ADHD
- Anti-racism
- Anxiety
- Assessment & screening
- Child mental health
- Coding
- Cognitive behavioral therapy
- College transition
- Culturally responsive
- Depression
- Eating disorders
- Foster care
- Grief
- High-risk children & youth
- LGBTQIA
- Medication
- Parents
- Patient communication
- Pediatric primary care
- School refusal
- Sleep disorders
- Suicide
- Trauma
- Show All Categories
Dates
Register for courses
“REACH offered a safe environment to learn and share in It was, and continues to be, a supportive, invigorating process! It was motivating and has increased my confidence in assessment, diagnosis of mental health cases in my day to day life and practice.”